| Stage | DCI | % of rev | ATR | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.1B | 100.00% | $1.0B | 100.00% | DCI ×1.04 |
| Gross profit | $384M | 36.26% | $373M | 36.59% | ATR +0.3pp |
| Operating income | $177M | 16.68% | $135M | 13.25% | DCI +3.4pp |
| Pre-tax income | $167M | 15.76% | $60M | 5.92% | DCI +9.8pp |
| Net income | $129M | 12.21% | $33M | 3.22% | DCI +9.0pp |
| Stage | DCI | ATR | Gap · A − B |
|---|---|---|---|
| Revenue | $1.1B100.00% | $1.0B100.00% | DCI ×1.04 |
| Gross profit | 36.26%$384M | 36.59%$373M | ATR +0.3pp |
| Operating income | 16.68%$177M | 13.25%$135M | DCI +3.4pp |
| Pre-tax income | 15.76%$167M | 5.92%$60M | DCI +9.8pp |
| Net income |
| 12.21%$129M |
| 3.22%$33M |
| DCI +9.0pp |
No disclosed counterparties: DCI, ATR.